$ADZA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ADEZA BIOMEDICAL CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ADEZA BIOMEDICAL CORP. Get notifications about new insider transactions in ADEZA BIOMEDICAL CORP for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 08 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.92 | 340 | 6,433 | 18,933 | 19.3 K to 18.9 K (-1.76 %) |
| Mar 08 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.89 | 220 | 4,156 | 19,273 | 19.5 K to 19.3 K (-1.13 %) |
| Mar 08 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.87 | 220 | 4,151 | 19,493 | 19.7 K to 19.5 K (-1.12 %) |
| Mar 08 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.76 | 220 | 4,127 | 19,713 | 19.9 K to 19.7 K (-1.10 %) |
| Mar 08 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.71 | 220 | 4,116 | 19,933 | 20.2 K to 19.9 K (-1.09 %) |
| Mar 08 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.58 | 100 | 1,858 | 20,153 | 20.3 K to 20.2 K (-0.49 %) |
| Mar 08 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.57 | 120 | 2,228 | 20,253 | 20.4 K to 20.3 K (-0.59 %) |
| Mar 08 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.56 | 200 | 3,712 | 20,373 | 20.6 K to 20.4 K (-0.97 %) |
| Mar 08 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.55 | 20 | 371 | 20,573 | 20.6 K to 20.6 K (-0.10 %) |
| Mar 08 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.43 | 8 | 147 | 20,593 | 20.6 K to 20.6 K (-0.04 %) |
| Mar 08 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.41 | 92 | 1,694 | 20,601 | 20.7 K to 20.6 K (-0.44 %) |
| Mar 08 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.40 | 120 | 2,208 | 20,693 | 20.8 K to 20.7 K (-0.58 %) |
| Mar 08 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.37 | 220 | 4,041 | 20,813 | 21 K to 20.8 K (-1.05 %) |
| Mar 08 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Buy | M | 0.97 | 1,200 | 1,164 | 21,033 | 19.8 K to 21 K (+6.05 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Option Exercise | M | 0.97 | 2,400 | 2,328 | 1,450 | |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Option Exercise | M | 0.97 | 800 | 776 | 6,115 | |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.25 | 12 | 267 | 19,833 | 19.8 K to 19.8 K (-0.06 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.24 | 408 | 9,074 | 19,845 | 20.3 K to 19.8 K (-2.01 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.23 | 200 | 4,446 | 20,253 | 20.5 K to 20.3 K (-0.98 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.21 | 120 | 2,665 | 20,453 | 20.6 K to 20.5 K (-0.58 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.18 | 120 | 2,662 | 20,573 | 20.7 K to 20.6 K (-0.58 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.17 | 200 | 4,434 | 20,693 | 20.9 K to 20.7 K (-0.96 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.16 | 100 | 2,216 | 20,893 | 21 K to 20.9 K (-0.48 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.15 | 440 | 9,746 | 20,993 | 21.4 K to 21 K (-2.05 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.14 | 200 | 4,428 | 21,433 | 21.6 K to 21.4 K (-0.92 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.13 | 100 | 2,213 | 21,633 | 21.7 K to 21.6 K (-0.46 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.07 | 100 | 2,207 | 21,733 | 21.8 K to 21.7 K (-0.46 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.06 | 200 | 4,412 | 21,833 | 22 K to 21.8 K (-0.91 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.05 | 20 | 441 | 22,033 | 22.1 K to 22 K (-0.09 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.04 | 320 | 7,053 | 22,053 | 22.4 K to 22.1 K (-1.43 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 22.00 | 20 | 440 | 22,373 | 22.4 K to 22.4 K (-0.09 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 21.95 | 320 | 7,024 | 22,393 | 22.7 K to 22.4 K (-1.41 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 21.94 | 320 | 7,021 | 22,713 | 23 K to 22.7 K (-1.39 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Buy | M | 0.97 | 2,400 | 2,328 | 23,033 | 20.6 K to 23 K (+11.63 %) |
| Feb 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Buy | M | 0.97 | 800 | 776 | 20,633 | 19.8 K to 20.6 K (+4.03 %) |
| Mar 02 2006 | ADZA | ADEZA BIOMEDICAL C ... | VONTZ CHARLES GREGORY | Director | Option Exercise | A | 22.20 | 22,500 | 499,500 | 22,500 | |
| Jan 05 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Option Exercise | M | 0.97 | 2,400 | 2,328 | 3,850 | |
| Jan 05 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Option Exercise | M | 0.97 | 800 | 776 | 6,915 | |
| Jan 05 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 21.09 | 151 | 3,185 | 19,833 | 20 K to 19.8 K (-0.76 %) |
| Jan 05 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 21.05 | 9 | 189 | 19,984 | 20 K to 20 K (-0.05 %) |
| Jan 05 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 21.03 | 100 | 2,103 | 19,993 | 20.1 K to 20 K (-0.50 %) |
| Jan 05 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 21.01 | 220 | 4,622 | 20,093 | 20.3 K to 20.1 K (-1.08 %) |
| Jan 05 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 21.00 | 80 | 1,680 | 20,313 | 20.4 K to 20.3 K (-0.39 %) |
| Jan 05 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 20.99 | 240 | 5,038 | 20,393 | 20.6 K to 20.4 K (-1.16 %) |
| Jan 05 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 20.98 | 40 | 839 | 20,633 | 20.7 K to 20.6 K (-0.19 %) |
| Jan 05 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 20.97 | 320 | 6,710 | 20,673 | 21 K to 20.7 K (-1.52 %) |
| Jan 05 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 20.89 | 40 | 836 | 20,993 | 21 K to 21 K (-0.19 %) |
| Jan 05 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 20.88 | 2,000 | 41,760 | 21,033 | 23 K to 21 K (-8.68 %) |
| Jan 05 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Buy | M | 0.97 | 2,400 | 2,328 | 23,033 | 20.6 K to 23 K (+11.63 %) |
| Jan 05 2006 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Buy | M | 0.97 | 800 | 776 | 20,633 | 19.8 K to 20.6 K (+4.03 %) |
| Dec 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.55 | 325 | 6,029 | 19,833 | 20.2 K to 19.8 K (-1.61 %) |
| Dec 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.92 | 322 | 6,092 | 20,158 | 20.5 K to 20.2 K (-1.57 %) |
| Dec 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.85 | 2,000 | 37,700 | 20,480 | 22.5 K to 20.5 K (-8.90 %) |
| Dec 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.67 | 546 | 10,194 | 22,480 | 23 K to 22.5 K (-2.37 %) |
| Dec 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.55 | 200 | 3,710 | 23,026 | 23.2 K to 23 K (-0.86 %) |
| Dec 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.92 | 200 | 3,784 | 23,226 | 23.4 K to 23.2 K (-0.85 %) |
| Dec 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.83 | 200 | 3,766 | 23,426 | 23.6 K to 23.4 K (-0.85 %) |
| Dec 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.82 | 200 | 3,764 | 23,626 | 23.8 K to 23.6 K (-0.84 %) |
| Dec 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.78 | 200 | 3,756 | 23,826 | 24 K to 23.8 K (-0.83 %) |
| Dec 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.77 | 200 | 3,754 | 24,026 | 24.2 K to 24 K (-0.83 %) |
| Dec 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.64 | 200 | 3,728 | 24,226 | 24.4 K to 24.2 K (-0.82 %) |
| Dec 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.55 | 200 | 3,710 | 24,426 | 24.6 K to 24.4 K (-0.81 %) |
| Dec 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.54 | 200 | 3,708 | 24,626 | 24.8 K to 24.6 K (-0.81 %) |
| Dec 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 18.42 | 200 | 3,684 | 24,826 | 25 K to 24.8 K (-0.80 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Option Exercise | M | 0.97 | 10,000 | 9,700 | 6,250 | |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Sell | S | 19.23 | 2,568 | 49,383 | 980 | 3.5 K to 980 (-72.38 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Sell | S | 19.24 | 932 | 17,932 | 3,548 | 4.5 K to 3.5 K (-20.80 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Sell | S | 19.26 | 200 | 3,852 | 4,480 | 4.7 K to 4.5 K (-4.27 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Sell | S | 19.27 | 500 | 9,635 | 4,680 | 5.2 K to 4.7 K (-9.65 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Sell | S | 19.30 | 5,100 | 98,430 | 5,180 | 10.3 K to 5.2 K (-49.61 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Sell | S | 19.29 | 100 | 1,929 | 10,280 | 10.4 K to 10.3 K (-0.96 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Sell | S | 19.28 | 600 | 11,568 | 10,380 | 11 K to 10.4 K (-5.46 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Buy | M | 0.97 | 10,000 | 9,700 | 10,980 | 980 to 11 K (+1,020.41 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Fischer-Colbrie Mark D | VP Finance and Admi ... | Option Exercise | M | 3.33 | 20,000 | 66,600 | 54,446 | |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Fischer-Colbrie Mark D | VP Finance and Admi ... | Sell | S | 19.17 | 1,000 | 19,172 | 0 | 1,000 to 0 (-100.00 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Fischer-Colbrie Mark D | VP Finance and Admi ... | Sell | S | 19.15 | 1,000 | 19,150 | 1,000 | 2 K to 1,000 (-50.00 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Fischer-Colbrie Mark D | VP Finance and Admi ... | Sell | S | 19.20 | 5,000 | 96,000 | 2,000 | 7 K to 2 K (-71.43 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Fischer-Colbrie Mark D | VP Finance and Admi ... | Sell | S | 19.22 | 1,000 | 19,219 | 7,000 | 8 K to 7 K (-12.50 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Fischer-Colbrie Mark D | VP Finance and Admi ... | Sell | S | 19.30 | 1,000 | 19,297 | 8,000 | 9 K to 8 K (-11.11 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Fischer-Colbrie Mark D | VP Finance and Admi ... | Sell | S | 19.15 | 2,000 | 38,300 | 9,000 | 11 K to 9 K (-18.18 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Fischer-Colbrie Mark D | VP Finance and Admi ... | Sell | S | 19.10 | 9,000 | 171,900 | 11,000 | 20 K to 11 K (-45.00 %) |
| Nov 22 2005 | ADZA | ADEZA BIOMEDICAL C ... | Fischer-Colbrie Mark D | VP Finance and Admi ... | Buy | M | 3.33 | 20,000 | 66,600 | 20,000 | 0 to 20 K |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Option Exercise | M | 3.33 | 96,156 | 320,199 | 0 | |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.42 | 2,000 | 34,840 | 25,423 | 27.4 K to 25.4 K (-7.29 %) |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.44 | 100 | 1,744 | 27,423 | 27.5 K to 27.4 K (-0.36 %) |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.38 | 2,000 | 34,760 | 27,523 | 29.5 K to 27.5 K (-6.77 %) |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.40 | 2,900 | 50,460 | 29,523 | 32.4 K to 29.5 K (-8.94 %) |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.32 | 5,000 | 86,600 | 32,423 | 37.4 K to 32.4 K (-13.36 %) |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.27 | 30,000 | 518,100 | 37,423 | 67.4 K to 37.4 K (-44.50 %) |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.28 | 14,000 | 241,920 | 67,423 | 81.4 K to 67.4 K (-17.19 %) |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.30 | 9,000 | 155,700 | 81,423 | 90.4 K to 81.4 K (-9.95 %) |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.36 | 6,000 | 104,160 | 90,423 | 96.4 K to 90.4 K (-6.22 %) |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.35 | 12,156 | 210,907 | 96,423 | 108.6 K to 96.4 K (-11.20 %) |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.37 | 13,000 | 225,810 | 108,579 | 121.6 K to 108.6 K (-10.69 %) |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Buy | M | 3.33 | 96,156 | 320,199 | 121,579 | 25.4 K to 121.6 K (+378.22 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Option Exercise | M | 3.33 | 30,000 | 99,900 | 96,156 | |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Option Exercise | M | 3.33 | 41,100 | 136,863 | 126,156 | |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.78 | 4 | 71 | 25,423 | 25.4 K to 25.4 K (-0.02 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.74 | 3 | 53 | 25,427 | 25.4 K to 25.4 K (-0.01 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.76 | 100 | 1,776 | 25,430 | 25.5 K to 25.4 K (-0.39 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.72 | 333 | 5,901 | 25,530 | 25.9 K to 25.5 K (-1.29 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.73 | 4,597 | 81,505 | 25,863 | 30.5 K to 25.9 K (-15.09 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.70 | 4,764 | 84,323 | 30,460 | 35.2 K to 30.5 K (-13.52 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.75 | 7,896 | 140,154 | 35,224 | 43.1 K to 35.2 K (-18.31 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.71 | 12,303 | 217,886 | 43,120 | 55.4 K to 43.1 K (-22.20 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Buy | M | 3.33 | 30,000 | 99,900 | 55,423 | 25.4 K to 55.4 K (+118.00 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 18.10 | 1,000 | 18,101 | 25,423 | 26.4 K to 25.4 K (-3.78 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 18.06 | 1,000 | 18,060 | 26,423 | 27.4 K to 26.4 K (-3.65 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 18.05 | 2,000 | 36,100 | 27,423 | 29.4 K to 27.4 K (-6.80 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 18.00 | 1,000 | 18,000 | 29,423 | 30.4 K to 29.4 K (-3.29 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.71 | 1,000 | 17,710 | 30,423 | 31.4 K to 30.4 K (-3.18 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.65 | 1,000 | 17,650 | 31,423 | 32.4 K to 31.4 K (-3.08 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 18.02 | 100 | 1,802 | 32,423 | 32.5 K to 32.4 K (-0.31 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.69 | 4,900 | 86,681 | 32,523 | 37.4 K to 32.5 K (-13.09 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 18.10 | 20,462 | 370,362 | 37,423 | 57.9 K to 37.4 K (-35.35 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.73 | 1,538 | 27,269 | 57,885 | 59.4 K to 57.9 K (-2.59 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.72 | 1,000 | 17,720 | 59,423 | 60.4 K to 59.4 K (-1.65 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Sell | S | 17.70 | 6,100 | 107,970 | 60,423 | 66.5 K to 60.4 K (-9.17 %) |
| Nov 15 2005 | ADZA | ADEZA BIOMEDICAL C ... | Anderson Emory V. | President and CEO | Buy | M | 3.33 | 41,100 | 136,863 | 66,523 | 25.4 K to 66.5 K (+161.66 %) |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | CREDIT SUISSE/ | 10% Owner | Sell | J | 17.68 | 259,814 | 4,593,512 | 1,599,754 | 1.9 M to 1.6 M (-13.97 %) |
| Nov 16 2005 | ADZA | ADEZA BIOMEDICAL C ... | CREDIT SUISSE/ | 10% Owner | Sell | J | 17.68 | 322,445 | 5,700,828 | 1,859,568 | 2.2 M to 1.9 M (-14.78 %) |
| Nov 07 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Option Exercise | M | 0.97 | 20,000 | 19,400 | 16,250 | |
| Nov 07 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Sell | S | 17.17 | 4,500 | 77,265 | 980 | 5.5 K to 980 (-82.12 %) |
| Nov 07 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Sell | S | 17.21 | 500 | 8,605 | 5,480 | 6 K to 5.5 K (-8.36 %) |
| Nov 07 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Sell | S | 17.20 | 5,000 | 86,000 | 5,980 | 11 K to 6 K (-45.54 %) |
| Nov 07 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Sell | S | 17.22 | 5,000 | 86,093 | 10,980 | 16 K to 11 K (-31.29 %) |
| Nov 07 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Sell | S | 17.22 | 5,000 | 86,100 | 15,980 | 21 K to 16 K (-23.83 %) |
| Nov 07 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hickok Durlin E | VP Medical Affairs | Buy | M | 0.97 | 20,000 | 19,400 | 20,980 | 980 to 21 K (+2,040.82 %) |
| Nov 07 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 17.26 | 3,477 | 60,003 | 25,026 | 28.5 K to 25 K (-12.20 %) |
| Nov 07 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 17.23 | 2,000 | 34,454 | 28,503 | 30.5 K to 28.5 K (-6.56 %) |
| Sep 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Sacco Marian E | VP Sales & Marketin ... | Option Exercise | M | 10.00 | 9,375 | 93,750 | 28,125 | |
| Sep 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Sacco Marian E | VP Sales & Marketin ... | Option Exercise | M | 3.33 | 10,625 | 35,381 | 30,625 | |
| Sep 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Sacco Marian E | VP Sales & Marketin ... | Sell | S | 17.00 | 14,000 | 238,000 | 0 | 14 K to 0 (-100.00 %) |
| Sep 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Sacco Marian E | VP Sales & Marketin ... | Sell | S | 16.95 | 6,000 | 101,700 | 14,000 | 20 K to 14 K (-30.00 %) |
| Sep 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Sacco Marian E | VP Sales & Marketin ... | Buy | M | 10.00 | 9,375 | 93,750 | 20,000 | 10.6 K to 20 K (+88.24 %) |
| Sep 02 2005 | ADZA | ADEZA BIOMEDICAL C ... | Sacco Marian E | VP Sales & Marketin ... | Buy | M | 3.33 | 10,625 | 35,381 | 10,625 | 0 to 10.6 K |
| Aug 31 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 16.66 | 1,000 | 16,663 | 30,503 | 31.5 K to 30.5 K (-3.17 %) |
| Aug 31 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 16.66 | 100 | 1,666 | 31,503 | 31.6 K to 31.5 K (-0.32 %) |
| Aug 31 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 16.65 | 1,000 | 16,650 | 31,603 | 32.6 K to 31.6 K (-3.07 %) |
| Aug 31 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 16.60 | 400 | 6,640 | 32,603 | 33 K to 32.6 K (-1.21 %) |
| Aug 31 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 16.59 | 1,000 | 16,591 | 33,003 | 34 K to 33 K (-2.94 %) |
| Aug 31 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 16.58 | 300 | 4,974 | 34,003 | 34.3 K to 34 K (-0.87 %) |
| Aug 31 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 16.56 | 1,000 | 16,564 | 34,303 | 35.3 K to 34.3 K (-2.83 %) |
| Aug 31 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 16.55 | 400 | 6,620 | 35,303 | 35.7 K to 35.3 K (-1.12 %) |
| Aug 31 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 16.54 | 1,800 | 29,772 | 35,703 | 37.5 K to 35.7 K (-4.80 %) |
| Aug 31 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 16.49 | 1,000 | 16,488 | 37,503 | 38.5 K to 37.5 K (-2.60 %) |
| Aug 31 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 16.49 | 1,000 | 16,486 | 38,503 | 39.5 K to 38.5 K (-2.53 %) |
| Aug 31 2005 | ADZA | ADEZA BIOMEDICAL C ... | Hussa Robert O | VP Research & Devel ... | Sell | S | 16.48 | 1,000 | 16,476 | 39,503 | 40.5 K to 39.5 K (-2.47 %) |
| Aug 26 2005 | ADZA | ADEZA BIOMEDICAL C ... | Fischer-Colbrie Mark D | VP Finance and Admi ... | Option Exercise | M | 3.33 | 20,000 | 66,600 | 74,446 | |
| Aug 26 2005 | ADZA | ADEZA BIOMEDICAL C ... | Fischer-Colbrie Mark D | VP Finance and Admi ... | Sell | S | 16.38 | 200 | 3,276 | 0 | 200 to 0 (-100.00 %) |